Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma
المؤلفون المشاركون
Imura, Yoshinori
Tamiya, Hironari
Sabe, Hideaki
Yamashita, Katsunari
Wakamatsu, Toru
Takenaka, Satoshi
المصدر
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-11-16
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Adriamycin-based chemotherapy is commonly used for malignant soft tissue sarcoma including myxoid liposarcoma.
However, in the case of unavailability or failure of the adriamycin-based regimen, trabectedin or eribulin can produce a good antitumor effect for myxoid liposarcoma.
We relate the experience of a 64-year-old female with myxoid liposarcoma, who noticed a nodule on her left thigh and visited our institute.
At initial presentation, the tumor was 18.7 cm in diameter, and the magnetic resonance imaging (MRI) showed a malignant lipomatous tumor with a myxoid component.
We recommended that she undergo treatment; however, she refused.
Three years later, the tumor had grown larger, so she finally decided to undergo treatment.
A needle biopsy revealed a myxoid liposarcoma.
The tumor massively involved the neurovascular structures; we thus determined that hip disarticulation was inevitable.
Two years later, metastases in the right thigh, left lung, right ileum, and abdominal space were pointed out and chemotherapy was initiated.
Adriamycin was unusable due to cardiac dysfunction, so trabectedin was administered; however, the tumors progressed.
Eribulin was subsequently started and has been considerably effective for more than 2 years without severe adverse effects.
In conclusion, we experienced a case showing the remarkable and long-lasting effect of eribulin against trabectedin-resistant myxoid liposarcoma.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Tamiya, Hironari& Sabe, Hideaki& Yamashita, Katsunari& Imura, Yoshinori& Wakamatsu, Toru& Takenaka, Satoshi. 2020. Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma. Case Reports in Orthopedics،Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1150124
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Tamiya, Hironari…[et al.]. Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma. Case Reports in Orthopedics No. 2020 (2020), pp.1-7.
https://search.emarefa.net/detail/BIM-1150124
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Tamiya, Hironari& Sabe, Hideaki& Yamashita, Katsunari& Imura, Yoshinori& Wakamatsu, Toru& Takenaka, Satoshi. Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma. Case Reports in Orthopedics. 2020. Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1150124
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1150124
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر